Skip to main content

Akebia Therapeutics, Inc. (NASDAQ: AKBA) Investor Securities Class Action Lawsuit 03/14/2022

  • If you purchased a significant amount of shares of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28, 2018 and September 2, 2020, and / or if you purchased any NASDAQ: AKBA shares prior to June 2018 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 13, 2022. NASDAQ: AKBA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 14,2022 - An investor in shares of Akebia Therapeutics, Inc. (NASDAQ: AKBA) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Akebia Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between June 28, 2018 and September 2, 2020. Cambridge, MA based Akebia...

You must register (for free) or login to view the entire case.